New workflow aims to prevent radiation errors in cancer treatment

NCT ID NCT07282444

Not yet recruiting Knowledge-focused Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This trial tests a new communication workflow called CORRECT that helps radiologists and radiation oncologists work together more effectively when planning radiation therapy for lung and head-and-neck cancers. About 194 patients will be involved, and doctors will use a shared system to review and improve treatment targets. The goal is to see if this process is practical and can reduce mistakes that might lead to cancer returning or unnecessary side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Collaborative Oncology between Radiologists and Radiation oncologists for the Evaluation of Contoured Targets (CORRECT) workflow
What this could lead to: If successful, this workflow could help reduce errors in radiation therapy planning, potentially lowering the risk of cancer recurrence or side effects.
What could go wrong: This is an early feasibility study, not a treatment trial. It tests a communication process, not a drug or device, so direct patient benefits are uncertain and may not change outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer head and neck carcinoma lung cancer lung carcinoma lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK CARCINOMA LUNG CARCINOMA

Contacts and locations

Locations

Wake Forest NCORP Research Base

Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.